Brittany C. Parker Kerrigan, PhD
Brittany C. Parker Kerrigan, PhD
MD Anderson Cancer Center, Dept. of Neurosurgery
Verified email at - Homepage
Cited by
Cited by
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
F Guo, BCP Kerrigan, D Yang, L Hu, I Shmulevich, AK Sood, F Xue, ...
Journal of hematology & oncology 7 (1), 1-11, 2014
MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer
G Liu, Y Sun, P Ji, X Li, D Cogdell, D Yang, BC Parker Kerrigan, ...
The Journal of pathology 233 (3), 308-318, 2014
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
FM Lang, A Hossain, J Gumin, EN Momin, Y Shimizu, D Ledbetter, ...
Neuro-oncology 20 (3), 380-390, 2018
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
BC Parker, M Engels, M Annala, W Zhang
The Journal of pathology 232 (1), 4-15, 2014
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
BC Parker, W Zhang
Chinese journal of cancer 32 (11), 594, 2013
Fusion genes and their discovery using high throughput sequencing
MJ Annala, BC Parker, W Zhang, M Nykter
Cancer letters 340 (2), 192-200, 2013
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas
BCP Kerrigan, Y Shimizu, M Andreeff, FF Lang
Cytotherapy 19 (4), 445-457, 2017
Tumor vaccines for malignant gliomas
VM Srinivasan, SD Ferguson, S Lee, SP Weathers, BCP Kerrigan, ...
Neurotherapeutics 14 (2), 345-357, 2017
Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress
P Yang, P Baciu, BCP Kerrigan, M Etheridge, E Sung, BA Toimil, ...
Investigative ophthalmology & visual science 55 (5), 3012-3021, 2014
Ionizing radiation augments glioma tropism of mesenchymal stem cells
JG Thomas, BCP Kerrigan, A Hossain, J Gumin, N Shinojima, F Nwajei, ...
Journal of neurosurgery 128 (1), 287-295, 2017
Immune modulatory nanoparticle therapeutics for intracerebral glioma
NK Yaghi, J Wei, Y Hashimoto, LY Kong, K Gabrusiewicz, EK Nduom, ...
Neuro-oncology 19 (3), 372-382, 2017
Translational genomics in cancer research: converting profiles into personalized cancer medicine
L Patel, B Parker, WZ Da Yang
Cancer biology & medicine 10 (4), 214, 2013
An integrated treatment delivery system for CSRS and CSRT and clinical applications
A Shiu, B Parker, JS Ye, J Lii
Journal of applied clinical medical physics 4 (4), 261-273, 2003
Linking inflammation and cancer: the unexpected SYK world
J Fueyo, MM Alonso, BC Parker Kerrigan, C Gomez-Manzano
Neuro-oncology 20 (5), 582-583, 2018
Stem cell therapy of gliomas
BCP Kerrigan, A Hossain, S Yamashita, FF Lang
Intracranial Gliomas Part III-Innovative Treatment Modalities 32, 124-151, 2018
Endovascular selective intra-arterial infusion of mesenchymal stem cells loaded with Delta-24 in a canine model
VM Srinivasan, J Gumin, KM Camstra, DE Collins, MM Chen, EJ Shpall, ...
Neurosurgery 88 (1), E102-E113, 2021
Targeting the tumor microenvironment in brain metastasis
N Giridharan, ICG Oliva, BJ O’Brien, BCP Kerrigan, AB Heimberger, ...
Neurosurgery Clinics 31 (4), 641-649, 2020
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells
VM Srinivasan, J Gumin, KM Camstra, SR Chen, JN Johnson, Y Shimizu, ...
Journal of neurosurgery 133 (4), 1182-1190, 2019
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine
BC Parker Kerrigan, D Ledbetter, M Kronowitz, L Phillips, J Gumin, ...
Neuro-oncology advances 2 (1), vdaa132, 2020
The system can't perform the operation now. Try again later.
Articles 1–20